| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |